Abstract
E2F1 is a potent inducer of apoptosis whereas its relative, E2F4, generally does not promote cell death. Other work from our laboratory has demonstrated that E2F1 can directly bind and represss the Mcl-1 promoter – contributing to E2F1-mediated apoptosis. Here we show that while E2F1 can repress the Mcl-1 promoter, other members of the E2F family (such as E2F4) cannot. Characterization of the Mcl-1 promoter demonstrates that the −143/+10 region is critical for E2F1-mediated downregulation. We demonstrate that the ability of E2F1 to repress the Mcl-1 promoter correlates with its ability to bind within the required −143/+10 region of this promoter. In contrast, E2F4 is unable to bind to the −143/+10 region of the Mcl-1 promoter. We propose that E2F4 is unable to repress the Mcl-1 promoter primarily as a result of insufficient binding to the essential regulatory region. This is the first evidence of DNA binding specificity among E2F family members that results in differential regulation of a naturally occurring promoter.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams PD, Kaelin Jr WG . 1996 Curr. Top. Microbiol. Immunol. 208: 79–93
Akgul C, Turner PC, White MR, Edwards SW . 2000 Cell. Mol. Life Sci. 57: 684–691
Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1998 Nature 391: 597–601
Cartwright P, Muller H, Wagener C, Holm K, Helin K . 1998 Oncogene 17: 611–623
Chao JR, Wang JM, Lee SF, Peng HW, Lin YH, Chou CH, Li JC, Huang HM, Chou CK, Kuo ML, Yen JJ, Yang-Yen HF . 1998 Mol. Cell. Biol. 18: 4883–4898
Cress WD, Johnson DG, Nevins JR . 1993 Mol. Cell. Biol. 13: 6314–6325
Cress WD, Nevins JR . 1996 Mol. Cell. Biol. 16: 2119–2127
Croxton R, Ma Y, Song L, Haura EB, Cress WD . 2001 Oncogene in press
Dagnino L, Fry CJ, Bartley SM, Farnham P, Gallie BL, Phillips RA . 1997a Mech. Dev. 66: 13–25
Dagnino L, Fry CJ, Bartley SM, Farnham P, Gallie BL, Phillips RA . 1997b Cell Growth Differ. 8: 553–563
DeGregori J, Kowalik T, Nevins JR . 1995 Mol. Cell. Biol. 15: 4215–4224
DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR . 1997 Proc. Natl. Acad. Sci. USA 94: 7245–7250
Flores AM, Kassatly RF, Cress WD . 1998 Oncogene 16: 1289–1298
Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ, La Thangue NB . 1993 Nature 362: 834–837
Harbour JW, Dean DC . 2000 Genes Dev. 14: 2393–2409
He Y, Armanious MK, Thomas MJ, Cress WD . 2000 Oncogene 19: 3422–3433
Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A . 1992 Cell 70: 337–350
Helin K, Wu C-L, Lees JA, Dynlacht BD, Ngwu C, Harlow E . 1993 Genes Dev. 7: 1850–1861
Hofmann F, Martelli F, Livingston DM, Wang Z . 1996 Genes Dev. 10: 2949–2959
Huber H, Edwards H, Goodhart PJ, Patrick DR, Huang PS, Ivey-Hoyle M, Barnett SF, Oliff A, Heimbrook DC . 1993 Proc. Natl. Acad. Sci. USA 90: 3525–3529
Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC . 1993 Mol. Cell. Biol. 13: 7802–7812
Johnson DG, Schwarz JK, Cress WD, Nevins JR . 1993 Nature 365: 349–352
Kaelin Jr WG, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK . 1992 Cell 70: 351–364
Kowalik TF, DeGregori J, Leone G, Jakoi L, Nevins JR . 1998 Cell Growth Differ. 9: 113–118
Kowalik TF, DeGregori J, Schwarz JK, Nevins JR . 1995 J. Virol. 69: 2491–2500
La Thangue NB . 1994 Curr. Opin. Cell. Biol. 6: 443–450
Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K . 1993 Mol. Cell. Biol. 13: 7813–7825
Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR . 2000 Mol. Cell. Biol. 20: 3626–3632
Lindeman GJ, Gaubatz S, Livingston DM, Ginsberg D . 1997 Proc. Natl. Acad. Sci. USA 94: 5095–5100
Luo RX, Postigo AA, Dean DC . 1998 Cell 92: 463–473
Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A . 1998 Nature 391: 601–605
Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, Rokas M, DePinho RA, Livingston DM, Grossman SR . 2001 Proc. Natl. Acad. Sci. USA 98: 4455–4460
Marti A, Wirbelauer C, Scheffner M, Krek W . 1999 Nat. Cell. Biol. 1: 14–19
Moberg K, Starz MA, Lees JA . 1996 Mol. Cell. Biol. 16: 1436–1449
Muller H, Moroni MC, Vigo E, Petersen BO, Bartek J, Helin K . 1997 Mol. Cell. Biol. 17: 5508–5520
Nevins JR . 1998 Cell Growth Differ. 9: 585–593
Ouellette MM, Cehn J, Wright WE, Shay JW . 1992 Oncogene 7: 1075–1081
Paramio JM, Segrelles C, Casanova ML, Jorcano JL . 2000 J. Biol. Chem. 275: 41219–41226
Persengiev SP, Kondova II, Kilpatrick DL . 1999 Mol. Cell. Biol. 19: 6048–6056
Puri PL, Balsano C, Burgio VL, Chirillo P, Natoli G, Ricci L, Mattei E, Graessmann A, Levrero M . 1997 Oncogene 14: 1171–1184
Qin XQ, Livingston DM, Kaelin Jr WG, Adams PD . 1994 Proc. Natl. Acad. Sci. USA 91: 10918–10922
Rogers KT, Higgins PD, Milla MM, Phillips RS, Horowitz JM . 1996 Proc. Natl. Acad. Sci. USA 93: 7594–7599
Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA . 1995 Proc. Natl. Acad. Sci. USA 92: 2403–2407
Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang XF, Nevins JR . 1995 Proc. Natl. Acad. Sci. USA 92: 483–487
Shan B, Lee WH . 1994 Mol. Cell. Biol. 14: 8166–8173
Tao Y, Kassatly RF, Cress WD, Horowitz JM . 1997 Mol. Cell. Biol. 17: 6994–7007
Tevosian SG, Paulson KE, Bronson R, Yee AS . 1996 Cell Growth Differ. 7: 43–52
Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T . 1998 Mol. Cell. 2: 293–304
Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA . 1997 Mol. Cell. Biol. 17: 7268–7282
Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC, Helin K . 1999 Mol. Cell. Biol. 19: 6379–6395
Wang D, Russell JL, Johnson DG . 2000 Mol. Cell. Biol. 20: 3417–3424
Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ, Yang-Yen HF . 1999 Mol. Cell. Biol. 19: 6195–6206
Wu CL, Zukerberg LR, Ngwu C, Harlow E, Lees JA . 1995 Mol. Cell. Biol. 15: 2536–2546
Wu X, Levine AJ . 1994 Proc. Natl. Acad. Sci. USA 91: 3602–3606
Zhang Y, Chellappan SP . 1995 Oncogene 10: 2085–2093
Acknowledgements
We thank Dr Eric Haura for helpful scientific discussion and comments on the manuscript. We also thank Drs Lanming Zhang and Marybeth Colter who performed DNA sequencing, and Mr Larry Kuba of the Molecular Imaging Core at H Lee Moffitt Cancer Center for assisting with the preparation of the manuscript. This work was supported by NCI Grant #CA78214 to WD Cress, by American Heart Association Southern Research Consortium Fellowship #9850018FRL to R Croxton, and by the H Lee Moffitt Comprehensive Cancer Center and Research Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Croxton, R., Ma, Y. & Cress, W. Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter. Oncogene 21, 1563–1570 (2002). https://doi.org/10.1038/sj.onc.1205232
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205232
Keywords
This article is cited by
-
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
Cell Death & Disease (2020)
-
Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors
Cell Death & Disease (2013)
-
Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia
Oncogene (2013)
-
Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death
Neurotoxicity Research (2012)
-
Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation
Oncogene (2005)